These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2406851)

  • 1. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts.
    Manhart MD
    Rev Infect Dis; 1990; 12 Suppl 1():S11-5. PubMed ID: 2406851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens.
    Pitz AM; Park GW; Lee D; Boissy YL; Vinjé J
    Gut Microbes; 2015; 6(2):93-100. PubMed ID: 25901890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of bismuth subsalicylate.
    Cornick NA; Silva M; Gorbach SL
    Rev Infect Dis; 1990; 12 Suppl 1():S9-10. PubMed ID: 2305178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth subsalicylate in the prevention of colonization of infant mice with Campylobacter jejuni.
    Hänninen ML
    Epidemiol Infect; 1990 Jun; 104(3):397-404. PubMed ID: 2347383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and killing of bacteria by bismuth subsalicylate.
    Sox TE; Olson CA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2075-82. PubMed ID: 2694949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
    Domenico P; Landolphi DR; Cunha BA
    J Antimicrob Chemother; 1991 Dec; 28(6):801-10. PubMed ID: 1816178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria.
    Gump DW; Nadeau OW; Hendricks GM; Meyer DH
    Med Microbiol Immunol; 1992; 181(3):131-43. PubMed ID: 1522823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bismuth subsalicylate on fecal microflora.
    Gorbach SL; Cornick NA; Silva M
    Rev Infect Dis; 1990; 12 Suppl 1():S21-3. PubMed ID: 2305174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae.
    Ericsson CD; Evans DG; DuPont HL; Evans DJ; Pickering LK
    J Infect Dis; 1977 Nov; 136(5):693-6. PubMed ID: 335003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of bismuth by Yersinia enterocolitica.
    Nadeau OW; Gump DW; Hendricks GM; Meyer DH
    Med Microbiol Immunol; 1992; 181(3):145-52. PubMed ID: 1522824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications.
    Vega-Jiménez AL; Almaguer-Flores A; Flores-Castañeda M; Camps E; Uribe-Ramírez M; Aztatzi-Aguilar OG; De Vizcaya-Ruiz A
    Nanotechnology; 2017 Oct; 28(43):435101. PubMed ID: 28837052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisecretory and antiinflammatory properties of bismuth subsalicylate.
    Ericsson CD; Tannenbaum C; Charles TT
    Rev Infect Dis; 1990; 12 Suppl 1():S16-20. PubMed ID: 2305173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wine as a digestive aid: comparative antimicrobial effects of bismuth salicylate and red and white wine.
    Weisse ME; Eberly B; Person DA
    BMJ; 1995 Dec 23-30; 311(7021):1657-60. PubMed ID: 8541747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bismuth subsalicylate increases intracellular Ca2+, MAP-kinase activity, and cell proliferation in normal human gastric mucous epithelial cells.
    Gilster J; Bacon K; Marlink K; Sheppard B; Deveney C; Rutten M
    Dig Dis Sci; 2004 Mar; 49(3):370-8. PubMed ID: 15139483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitigation of in vitro hydrogen sulfide production using bismuth subsalicylate with and without monensin in beef feedlot diets.
    Ruiz-Moreno M; Binversie E; Fessenden SW; Stern MD
    J Anim Sci; 2015 Nov; 93(11):5346-54. PubMed ID: 26641054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro bile acid adsorption by bismuth subsalicylate and montmorillonite.
    Kocoshis SA; Ghent CN; Gryboski JD
    Dig Dis Sci; 1984 Dec; 29(12):1148-52. PubMed ID: 6499633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bismuth subsalicylate in the treatment and prevention of diarrheal disease.
    DuPont HL
    Drug Intell Clin Pharm; 1987 Sep; 21(9):687-93. PubMed ID: 3308391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.